@dakami Hm, this scientific article looks interesting. I'll come back after digesting it. Thanks for bringing up insulin. Specific examples are easier to reason about. https://t.co/c4WwDWxnrR
@DearAuntCrabby Insulin has been around for almost 100 years. Human insulin costs are nowhere near as high as human analog insulins. This article may shed light. Only 3 drug companies manufacture insulin. And how they push the insulin pens, which cost mor
@webDM1 @jose87 @FDAMedWatch Como muestra un botón https://t.co/vIS2Ra6yTx
Insulin Access and Affordability Working Group: Conclusions and Recommendations https://t.co/jGuShib4QV
@1a @Kidfears99 Just calculated the effect of @LillyPad Basaglar’s CAGR from my diagnosis in 2001 to 40 years down the road 🤞🏻 This is how the insulin cartel costs the U.S. more than $327 b per year https://t.co/rSdtjQTrHQ https://t.co/o3Zzsatcss
RT @DanielJDrucker: @picardonhealth @GlobeDebate The massive missed opportunity to supply #insulin4all at a reasonable price #diabetes is a…
Canada needs to lower blood sugar in T2D with therapeutic nutrition...thereby reducing insulin demand and price... https://t.co/SJgwCwQuEm
RT @DanielJDrucker: @picardonhealth @GlobeDebate The massive missed opportunity to supply #insulin4all at a reasonable price #diabetes is a…
@picardonhealth @GlobeDebate The massive missed opportunity to supply #insulin4all at a reasonable price #diabetes is a huge stain on the way drugs are priced and delivered in the USA-a murky shameful business that desperately needs fixing-The lawyers ulti
@WhatsNewDonehue @mutedtempest @Valkgurl @washingtonpost I defer to the American Diabetes Association which advised physicians to prescribe older insulins https://t.co/drlYAv51oo
@ddiamond @emilyrauhala @juliaoftoronto I defer to the American Diabetes Association which advised physicians to prescribe older insulins https://t.co/drlYAv51oo
@ReidHansenMO No problem: “Currently, there are only three insulin manufacturers serving the U.S. market: Eli Lilly, Novo Nordisk, and Sanofi.” https://t.co/e3MFxND4dk “...and they vigorously defend their formulations against cheaper biosimilar versions
RT @DanielJDrucker: @DiabetesMine @NSmithholt12 Down the rabbit hole of the #Insulin4all supply chain. We must all do better Insulin Access…
RT @DanielJDrucker: @DiabetesMine @NSmithholt12 Down the rabbit hole of the #Insulin4all supply chain. We must all do better Insulin Access…
@DiabetesMine @NSmithholt12 Down the rabbit hole of the #Insulin4all supply chain. We must all do better Insulin Access and Affordability Working Group: Conclusions and Recommendations https://t.co/3dkTbnGJgO
Not working out too well for people with Diabetes that need insulin... https://t.co/qubuYhA9Tj https://t.co/WdbB7jaRGX
Some fun charts I found plus the markup source I used and good links to learn more https://t.co/Cd5cHGy94u https://t.co/BO2v3d6bRH https://t.co/ZzUqrnojHg
RT @eeberquist: @nk_prof @MangroveStar @bdk1521 I don't understand all the nuances, but from what I've read it's not simply the manufacture…
RT @eeberquist: @nk_prof @MangroveStar @bdk1521 I don't understand all the nuances, but from what I've read it's not simply the manufacture…
RT @eeberquist: @nk_prof @MangroveStar @bdk1521 I don't understand all the nuances, but from what I've read it's not simply the manufacture…
RT @eeberquist: @nk_prof @MangroveStar @bdk1521 I don't understand all the nuances, but from what I've read it's not simply the manufacture…
RT @eeberquist: @nk_prof @MangroveStar @bdk1521 I don't understand all the nuances, but from what I've read it's not simply the manufacture…
@nk_prof @MangroveStar @bdk1521 I don't understand all the nuances, but from what I've read it's not simply the manufacturers increasing the price, it's the added costs of the supply chain (including health plans), which m4a would hopefully be better able
RT @RobinParisotto1: The elephant in the room keeps getting ignored https://t.co/2kjFCTrATw
That's because it would mean denouncing a multi bln 💲💲 industry which you could argue causes alot of our current health issues, not just diabetes. Sugar is used in almost all processed foods. Shit, they put it in baby formula to get us hooked early. And go
Just say no
The elephant in the room keeps getting ignored
Drug companies are worse then criminals in the US, the Mafia is organized crime and so are they.
@CTV_AvisFavaro @business The insulin (drug) supply chain #diabetes is a mess in USA. Nevertheless, despite producing hundreds of life-saving drugs, and saving/improving lives, industry often manages to find ways to snatch defeat from the jaws of certain p
@zachsmith930 @SenSanders https://t.co/6syCf45Nlc From what I've read, it's less manufacturers life Eli Lily, Novo, and more a dysfunctional supply chain, where insurance companies, pharmacy benefit managers only cover more expensive formulations to maxim
@EconTalker @SenSanders Good article here: https://t.co/5Rs3DrnFe4 - may be more than you want to know
RT @saratraigle: Appreciate @SenateFinance included the invaluable patient perspective from Kathy Sego yesterday! More #patientengagement i…
Appreciate @SenateFinance included the invaluable patient perspective from Kathy Sego yesterday! More #patientengagement is key so we advance #patientcentered solutions on #drugpricing such as more #CER #Patients4PCORI @SenateFinance @pipcpatients https://
Incentives in #insulin supply chain facilitate and may promote high #drugprices via 2018 working group @ADA_Journals @AmDiabetesAssn https://t.co/UMpt1CeHjD #diabetes #drugpricing (inc. Schaeffer researchers Dana Goldman & Karen Van Nuys)
@athenatsimikas @AliceYYCheng Insulin pricing is one prominent canary in the nightmare US drug distribution system. It is broken A made in the USA travesty https://t.co/FvhtILDyF7
@novonordiskus The Black Box of the #insulin Supply Chain per the Access and Affordability Working Group: Conclusions and Recommendations | Diabetes Care https://t.co/FvhtILlXgx
Medication for diabetes, Heart disease, Epi-pen should not cost an arm and a leg. This is criminal.
This whole thread is relevant to my thoughts today.
Thank you C+H
RT @JohnTuckerPhD: The article further noted that the price of Humalog had risen by 138% over a 6 year period, but only 6% of that increas…
RT @DrJMLuther: @thebyrdlab @DShaywitz @efunkEM @jflier @C_Garthwaite @zakkohane Lock-step price increase in insulin pricing...highlighted…
RT @DrJMLuther: @thebyrdlab @DShaywitz @efunkEM @jflier @C_Garthwaite @zakkohane Lock-step price increase in insulin pricing...highlighted…
@thebyrdlab @DShaywitz @efunkEM @jflier @C_Garthwaite @zakkohane Lock-step price increase in insulin pricing...highlighted in this ADA position statement. https://t.co/YksTqsRq6O https://t.co/5NBFoxuoUz
@sbaroncohen @jnmedina8989 The price of #insulin is only high in the United States due 2 US govt. regulation. Insulin cost 1/10th US prices overseas, but it is illegal 4 Americans to purchase it. The non-market US insurance payment model is also partly res
@jeffreyatucker can you explain this apparent market failure? https://t.co/9yHftJCAGe
RT @RothschildMark: #insulin manufacturer *net* profits r stable or declining, but patients r indeed paying more. Patients' costs 4 insulin…
#insulin manufacturer *net* profits r stable or declining, but patients r indeed paying more. Patients' costs 4 insulin r increasing bc profits r disappearing into a an opaque web of rebates between pharmacies, PBM, & health insurance providers. https
@ZephyrTeachout #insulin manufacturer *net* profits r stable or declining, but patients r indeed paying more. Patients' costs 4 insulin r increasing bc profits r disappearing into a an opaque web of rebates between pharmacies, PBM, & health insurance p
#insulin manufacturer *net* profits r stable or declining, but patients r indeed paying more. Patients' costs 4 insulin r increasing bc profits r disappearing into a an opaque web of rebates between pharmacies, PBM, & health insurance providers. http
Access to insulin is critical for people with diabetes. The American Diabetes Association recently concluded a working group study on why insulin prices keep rising. Read their findings: https://t.co/nPit9GCPyu @ADA_Journals
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
Insulin Access and Affordability Working Group: Conclusions and Recommendations https://t.co/RYnTibyVys
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
Food IS Medicine....(Hippocrates,natch!) https://t.co/6iJzIKaoCC
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
Insulin Access and Affordability Working Group: Conclusions and Recommendations https://t.co/cfnaaDESAk via @instapaper
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @DrAjitKorgaokar: I don’t understand why insulin is increasing in cost, when the opposite should happen given the increasing demand. So…
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
I don’t understand why insulin is increasing in cost, when the opposite should happen given the increasing demand. Something is not right here. Someone’s making a unethical profit https://t.co/k74Re0os9I
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
Lets find out how to solve a problem, then take that solution and put it on the tallest mountain and deepest cavern, where no one can find it! Its a pathetic state of affairs! #sugarkills https://t.co/VvCrMy2FDv
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @DanielJDrucker: @jflier From serious adversity, we must find solutions, through transparency and accountability. The supply chain is a…
@jflier From serious adversity, we must find solutions, through transparency and accountability. The supply chain is a black box. Imagine the benefits to the #insulin company that shows real leadership in providing reasonable #insulin4all https://t.co/Fvht
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
Consensus statement on #insulin access and affordability released by @AmDiabetesAssn. Critical topic for millions of people living with #diabetes. Read it here: https://t.co/Lvxlq2tz2Z https://t.co/86FFJIpQHU
RT @LowCarbVet: The price for a bottle of Lantus insulin is around $330. We tell the owners there us an 80% chance the cat will be in remis…
RT @MichLitch: This is critical. The cost difference places Medicare beneficiaries into the donut hole a lot sooner. They also cannot use t…
RT @MichLitch: Great thread on insulin cost #diabetes https://t.co/MUxLIYAwSq
Great thread on insulin cost #diabetes https://t.co/MUxLIYAwSq
This is critical. The cost difference places Medicare beneficiaries into the donut hole a lot sooner. They also cannot use the pharma coupons. I’ve seen firsthand people go without, decrease doses - nothing good comes from any of it. #MakeHealthAffordable
RT @joyclee: Report on Insulin Access and Affordability Working Group: Conclusions and Recommendations from the ADA https://t.co/8RvWTDbrS2…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
RT @joyclee: Report on Insulin Access and Affordability Working Group: Conclusions and Recommendations from the ADA https://t.co/8RvWTDbrS2…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
RT @joyclee: "Insulin Supply Chain: A complex system" "Complex" is a horrible euphemism for what is happening https://t.co/8RvWTDbrS2 #Insu…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
RT @joyclee: Report on Insulin Access and Affordability Working Group: Conclusions and Recommendations from the ADA https://t.co/8RvWTDbrS2…
RT @joyclee: Report on Insulin Access and Affordability Working Group: Conclusions and Recommendations from the ADA https://t.co/8RvWTDbrS2…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
Has always sounded like price fixing to me https://t.co/yp0fC3bkkO
RT @joyclee: Report on Insulin Access and Affordability Working Group: Conclusions and Recommendations from the ADA https://t.co/8RvWTDbrS2…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
RT @joyclee: Report on Insulin Access and Affordability Working Group: Conclusions and Recommendations from the ADA https://t.co/8RvWTDbrS2…
RT @MelindaMWedding: Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hw…
Dr. Lee has created the ultimate explainer thread on insulin pricing. This is masterful. #insulin4all https://t.co/hwU9LA9JKy
RT @davidludwigmd: American Diabetes Association released a new report on sky-rocketing cost of insulin, including recommendations for cost…
RT @joyclee: "when one insulin manufacturer increases the price for a given insulin formulation, the other insulin manufacturers often incr…
RT @MTL613: About the ADA white paper on insulin access/affordability. #dsma #insulin4all https://t.co/7z4LbOqYw7
RT @joyclee: "when one insulin manufacturer increases the price for a given insulin formulation, the other insulin manufacturers often incr…